Advertisement

PetVivo Holdings, Inc. PETV

Set alert

Price alert · PETV

All alert types
0.65 USD -0.04 -5.15%

As of Oct 30, 3:22 PM ET

0.64 Day range 0.645
0.624 52-week range 1.46
YTD
-43.42%
1 year
-54.58%
Open
0.64
Prev close
0.68
Mkt cap
24.48M
Vol
102
Avg vol
11.47K
EPS
-0.34
P/E
0.00
Div yield
0.00%
More statistics
Low
0.64
High
0.645
Forward P/E
-0.96
Beta
2.10
Short ratio
4.45
Inst. own
5.27%
Dividend
0.00
Ex-div date
50-d avg
0.92812
200-d avg
1.35
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 14, 2024Earnings: -0.11; estimate 0; surprise —%
Signals (77)
NameDateAgo
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 13, 20262 weeks ago
SMA: BearishOct 12, 20262 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 6, 20263 weeks ago
MACD: Sell SignalOct 2, 20264 weeks ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishSep 21, 20261 month ago
RSI: OverboughtSep 21, 20261 month ago
SMA: BullishSep 16, 20261 month ago
MACD: Buy SignalAug 10, 20262 months ago
SMA: BearishJul 13, 20263 months ago
MACD: Sell SignalJul 7, 20263 months ago
MACD: Buy SignalJun 9, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 3, 20265 months ago
SMA: BullishJun 2, 20265 months ago
SMA: BearishMay 29, 20265 months ago
MACD: Sell SignalMay 29, 20265 months ago
MACD: Buy SignalMay 27, 20265 months ago
SMA: BullishMay 19, 20265 months ago
SMA: BearishMay 18, 20265 months ago
MACD: Sell SignalMay 18, 20265 months ago
MACD: Buy SignalMay 14, 20265 months ago
SMA: BullishMay 13, 20265 months ago
SMA: BearishMay 12, 20265 months ago
MACD: Sell SignalMay 12, 20265 months ago
MACD: Buy SignalMay 8, 20265 months ago
MACD: Sell SignalMay 5, 20265 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalApr 10, 20266 months ago
MACD: Sell SignalMar 27, 20267 months ago
MACD: Buy SignalFeb 25, 20268 months ago
RSI: OversoldFeb 9, 20268 months ago
MACD: Sell SignalFeb 3, 20269 months ago
SMA: BearishFeb 2, 20269 months ago
MACD: Buy SignalJan 29, 20269 months ago
SMA: BullishJan 28, 20269 months ago
SMA: BearishJan 27, 20269 months ago
MACD: Sell SignalJan 9, 20269 months ago
MACD: Buy SignalJan 2, 202610 months ago
MACD: Sell SignalDec 30, 202510 months ago
MACD: Buy SignalDec 12, 202510 months ago
MACD: Sell SignalDec 11, 202510 months ago
MACD: Buy SignalDec 10, 202510 months ago
SMA: BearishNov 25, 202511 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 17, 202511 months ago
MACD: Sell SignalOct 31, 20251 year ago
RSI: OverboughtOct 27, 20251 year ago
MACD: Buy SignalOct 24, 20251 year ago
MACD: Sell SignalOct 20, 20251 year ago
RSI: OverboughtSep 30, 20251 year ago
RSI: OverboughtSep 18, 20251 year ago
MACD: Buy SignalSep 10, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BearishSep 2, 20251 year ago
SMA: BullishAug 29, 20251 year ago
SMA: BearishAug 28, 20251 year ago
MACD: Sell SignalAug 14, 20251 year ago
MACD: Buy SignalAug 5, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
MACD: Buy SignalJul 18, 20251 year ago
MACD: Sell SignalJul 7, 20251 year ago
MACD: Buy SignalJun 25, 20251 year ago
MACD: Sell SignalMay 30, 20251 year ago
RSI: OverboughtMay 13, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
MACD: Sell SignalApr 11, 20251 year ago
SMA: BearishApr 4, 20251 year ago
SMA: BullishApr 2, 20251 year ago
MACD: Buy SignalMar 14, 20251 year ago
SMA: BearishFeb 18, 20251 year ago
MACD: Sell SignalJan 23, 20251 year ago
RSI: OverboughtJan 2, 20251 year ago
MACD: Buy SignalDec 20, 20241 year ago

Key statistics

Market cap
12.07M
Enterprise value
14.82M
Trailing P/E
0.00
Forward P/E
-0.96
PEG ratio
0.00
Price / sales
11.54
Price / book
12.00
EPS (TTM)
-0.85
Beta
2.10
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.05M
Revenue growth
16.80%
Free cash flow
-4.02M
Total cash
80.08K
Total debt
1.40M
Return on equity
-1266.46%
Shares outstanding
16.77M
Short % of float
1.00%
50-day average
0.92812
200-day average
1.35

Analyst view

Consensus: buy

Buy
Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PETV Revenue — quarterly 595.89K
2020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 2023
PETV Net income — quarterly -1.75M
2020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 2023
PETV EPS — quarterly -0.12
2020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20202021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 2023

Earnings

PETV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.11——
Aug 14, 2024Jun 1, 20240.00-0.11——
Jun 28, 2024Mar 1, 20240.00-0.14——
Feb 12, 2024Dec 1, 20230.00-0.12——
Nov 14, 2023Sep 1, 20230.00-0.23——
Aug 10, 2023Jun 1, 20230.00-0.25——

Upgrades / downgrades

PETV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 11, 2021ThinkEquityinit—Buy

About PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
petvivo.com

News

Your note

Sign in to keep a note on PETV — it syncs with the Stock Master app.

Insider holders

PETV insider holders
InsiderRelationLatest transactionDateShares held
CASH GREGORY DDirectorConversion of Exercise of derivative securityJun 29, 202259,267
COSTANTINO ROBERT JDirectorPurchaseMar 14, 20239,703
DEMING DAVID DONDirectorStock Award(Grant)Sep 30, 202129,890
DOLAN JOHN FITZGERALDOfficer and DirectorStock Award(Grant)Sep 8, 2021541,239
JASPER JOSEPH WILLIAMDirectorPurchaseMar 12, 20230
JOHNSON SCOTT MITCHELLDirectorStock Award(Grant)Sep 30, 2021169,726

Institution ownership

PETV institution ownership
Holder% heldSharesValueReported
Bard Associates Inc.6.15%436,500859.90KJun 29, 2023
Vanguard Group Inc3.29%233,055459.12KJun 29, 2023
Geode Capital Management, LLC0.66%47,04592.68KJun 29, 2023
State Street Corporation0.65%46,22991.07KJun 29, 2023
Regal Investment Advisors, LLC0.30%21,37742.11KJun 29, 2023
Asset Dedication, Llc0.21%14,56928.70KJun 29, 2023

Fund ownership

PETV fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.44%173,200341.20KJun 29, 2023
Vanguard Extended Market Index Fund0.84%59,855117.91KJun 29, 2023
Fidelity Extended Market Index Fund0.39%27,82057.87KMay 30, 2023
Fidelity NASDAQ Composite Index Fund0.17%12,29825.58KMay 30, 2023
Fidelity Series Total Market Index Fund0.05%3,2916.84KMay 30, 2023
Advertisement